Post-earnings recap
Reported
Tue, May 1, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Incyte Corp's earnings report showed a small loss per share, which was below expectations. The stock reacted negatively, declining by 1.76%. Investors may be concerned about the absence of revenue figures and future guidance, which could indicate uncertainty in the company's near-term performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.01 | N/A | -112.07% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding future performance due to the lack of specific guidance. They emphasized their commitment to advancing their pipeline.
Management did not provide specific guidance for the upcoming quarters.
The company is focusing on ongoing clinical trials and product development.